These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34975856)

  • 1. C3a Receptor Signaling Inhibits Neurodegeneration Induced by Neonatal Hypoxic-Ischemic Brain Injury.
    Pozo-Rodrigálvarez A; Li Y; Stokowska A; Wu J; Dehm V; Sourkova H; Steinbusch H; Mallard C; Hagberg H; Pekny M; Pekna M
    Front Immunol; 2021; 12():768198. PubMed ID: 34975856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor for complement peptide C3a: a therapeutic target for neonatal hypoxic-ischemic brain injury.
    Järlestedt K; Rousset CI; Ståhlberg A; Sourkova H; Atkins AL; Thornton C; Barnum SR; Wetsel RA; Dragunow M; Pekny M; Mallard C; Hagberg H; Pekna M
    FASEB J; 2013 Sep; 27(9):3797-804. PubMed ID: 23737250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal C3a treatment ameliorates cognitive impairment in a mouse model of neonatal hypoxic-ischemic brain injury.
    Morán J; Stokowska A; Walker FR; Mallard C; Hagberg H; Pekna M
    Exp Neurol; 2017 Apr; 290():74-84. PubMed ID: 28062175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Complement C3a Receptor to Improve Outcome After Ischemic Brain Injury.
    Pekna M; Stokowska A; Pekny M
    Neurochem Res; 2021 Oct; 46(10):2626-2637. PubMed ID: 34379293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decay accelerating factor (CD55) protects neuronal cells from chemical hypoxia-induced injury.
    Wang Y; Li Y; Dalle Lucca SL; Simovic M; Tsokos GC; Dalle Lucca JJ
    J Neuroinflammation; 2010 Apr; 7():24. PubMed ID: 20380727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Complement C3a Receptor in Stroke.
    Ahmad S; Bhatia K; Kindelin A; Ducruet AF
    Neuromolecular Med; 2019 Dec; 21(4):467-473. PubMed ID: 31102134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic hypothermia modulates complement factor C3a and C5a levels in a rat model of hypoxic ischemic encephalopathy.
    Shah TA; Nejad JE; Pallera HK; Lattanzio FA; Farhat R; Kumar PS; Hair PS; Bass WT; Krishna NK
    Pediatr Res; 2017 Apr; 81(4):654-662. PubMed ID: 28002390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C3aR inhibition reduces neurodegeneration in experimental lupus.
    Jacob A; Bao L; Brorson J; Quigg RJ; Alexander JJ
    Lupus; 2010 Jan; 19(1):73-82. PubMed ID: 19900981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement C3a treatment accelerates recovery after stroke via modulation of astrocyte reactivity and cortical connectivity.
    Stokowska A; Aswendt M; Zucha D; Lohmann S; Wieters F; Morán Suarez J; Atkins AL; Li Y; Miteva M; Lewin J; Wiedermann D; Diedenhofen M; Torinsson Naluai Å; Abaffy P; Valihrach L; Kubista M; Hoehn M; Pekny M; Pekna M
    J Clin Invest; 2023 May; 133(10):. PubMed ID: 36995772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement C3a Receptor (C3aR) Mediates Vascular Dysfunction, Hippocampal Pathology, and Cognitive Impairment in a Mouse Model of VCID.
    Bhatia K; Kindelin A; Nadeem M; Khan MB; Yin J; Fuentes A; Miller K; Turner GH; Preul MC; Ahmad AS; Mufson EJ; Waters MF; Ahmad S; Ducruet AF
    Transl Stroke Res; 2022 Oct; 13(5):816-829. PubMed ID: 35258803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis.
    Boos L; Campbell IL; Ames R; Wetsel RA; Barnum SR
    J Immunol; 2004 Oct; 173(7):4708-14. PubMed ID: 15383607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement C3a signaling facilitates skeletal muscle regeneration by regulating monocyte function and trafficking.
    Zhang C; Wang C; Li Y; Miwa T; Liu C; Cui W; Song WC; Du J
    Nat Commun; 2017 Dec; 8(1):2078. PubMed ID: 29233958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement C3a receptor-mediated vascular dysfunction: a complex interplay between aging and neurodegeneration.
    Bhatia K; Ahmad S; Kindelin A; Ducruet AF
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33393493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective engraftment of C3aR-/- hematopoietic stem progenitor cells shows a novel role of the C3a-C3aR axis in bone marrow homing.
    Wysoczynski M; Reca R; Lee H; Wu W; Ratajczak J; Ratajczak MZ
    Leukemia; 2009 Aug; 23(8):1455-61. PubMed ID: 19357704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C3aR signaling and gliosis in response to neurodevelopmental damage in the cerebellum.
    Young KG; Yan K; Picketts DJ
    J Neuroinflammation; 2019 Jul; 16(1):135. PubMed ID: 31272467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement: a novel factor in basal and ischemia-induced neurogenesis.
    Rahpeymai Y; Hietala MA; Wilhelmsson U; Fotheringham A; Davies I; Nilsson AK; Zwirner J; Wetsel RA; Gerard C; Pekny M; Pekna M
    EMBO J; 2006 Mar; 25(6):1364-74. PubMed ID: 16498410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous hypothermic response to hypoxia reduces brain injury: Implications for modeling hypoxic-ischemic encephalopathy and therapeutic hypothermia in neonatal mice.
    Reinboth BS; Köster C; Abberger H; Prager S; Bendix I; Felderhoff-Müser U; Herz J
    Exp Neurol; 2016 Sep; 283(Pt A):264-75. PubMed ID: 27349408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats.
    Kumral A; Uysal N; Tugyan K; Sonmez A; Yilmaz O; Gokmen N; Kiray M; Genc S; Duman N; Koroglu TF; Ozkan H; Genc K
    Behav Brain Res; 2004 Aug; 153(1):77-86. PubMed ID: 15219709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C3a expressed in the central nervous system protects against LPS-induced shock.
    Boos L; Szalai AJ; Barnum SR
    Neurosci Lett; 2005 Oct; 387(2):68-71. PubMed ID: 16085360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperactive Behavior and Altered Brain Morphology in Adult Complement C3a Receptor Deficient Mice.
    Pozo-Rodrigálvarez A; Ollaranta R; Skoog J; Pekny M; Pekna M
    Front Immunol; 2021; 12():604812. PubMed ID: 33692783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.